Companion Diagnostics for Oncology Market Regional Analysis

North America is slated to hold sway over global companion diagnostics for oncology demand outlook across the forecast period. This dominance can be attributed to surging prevalence of different cancers and high investments in oncology research are key factors that allow North America to account for a dominant stance in the global companion diagnostics for oncology marketplace. High availability of grants and subsidies for oncology research are also helping North America to maintain its dominance. The United States and Canada are projected to be the leading markets for companion diagnostics for oncology providers in this region.

High emphasis on healthcare infrastructure development and growing approval of novel oncology treatments and medical devices help Asia Pacific region become the fastest-growing regional market in the world. Supportive government initiatives to promote oncology R&D are also slated to create new opportunities for companion diagnostics providers based in this region going forward. China, India, and Japan are slated to be the top markets for companion diagnostics for oncology companies operating in the Asia Pacific region.